Soluble Fas ligand released by colon adenocarcinoma cells induces host lymphocyte apoptosis: an active mode of immune evasion in colon cancer

Citation
E. Song et al., Soluble Fas ligand released by colon adenocarcinoma cells induces host lymphocyte apoptosis: an active mode of immune evasion in colon cancer, BR J CANC, 85(7), 2001, pp. 1047-1054
Citations number
39
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
BRITISH JOURNAL OF CANCER
ISSN journal
00070920 → ACNP
Volume
85
Issue
7
Year of publication
2001
Pages
1047 - 1054
Database
ISI
SICI code
0007-0920(20010928)85:7<1047:SFLRBC>2.0.ZU;2-5
Abstract
Expression of membrane-bound Fas ligand (mFasL) on colon cancer cells serve s as a potential mechanism to inhibit host immune function by inducing apop tosis of host lymphocytes, Membrane-bound FasL can be cleaved and released as a soluble mediator (sFasL), which may spread the apoptosis induction eff ect. Our study examined whether colon adenocarcinoma cells release sFasL, a nd induce apoptosis of host lymphocytes without direct cell-cell contact. I n 12 consecutive patients with colon adenocarcinoma mFasL was identified in the tumours, sFasL was measured in the sera and apoptosis identified in tu mour-infiltrating and peripheral blood lymphocytes. To analyse the function of sFasL, colon cancer cells were primarily cultured; sFasL was isolated f rom supernatants, measured, incubated with Fas-bearing Jurkat cells, and th e resulting apoptosis was analysed. Serum levels of sFasL were significantl y elevated in ail colon cancer patients with mFasL expression in tumour tis sues (n = 8). In these patients, the number of apoptotic lymphocytes was si gnificantly increased within tumour and peripheral blood, Furthermore, sFas L was present in the corresponding supernatants and induced apoptosis of Ju rkat cells in a close-dependent manner. These findings suggest that mFasL-p ositive colon cancer cells release sFasL, and thus may induce apoptosis of host lymphocytes as a potential mechanism for immune evasion. (C) 2001 Canc er Research Campaign http://www.bjcancer.com.